Loading…
Loading…
Editorial note: Market figures cited in this article are estimates based on publicly available industry reports and may vary by source. HalalExpo.com aims to present the most current data available but readers should verify figures for business decisions. Sources include the State of the Global Islamic Economy Report, DinarStandard, and national halal authority publications.
Pharmaceutical products present a unique halal compliance challenge. Many common medicines contain ingredients derived from non-halal sources: porcine gelatin in capsule shells, alcohol-based solvents, and excipients derived from animal fats. For observant Muslims, taking medication that contains haram ingredients raises a religious dilemma — particularly when halal alternatives exist but are not readily available or clearly labelled.
The global Muslim population exceeds 1.9 billion people. As awareness of halal pharmaceutical issues grows and as Muslim-majority countries develop regulatory frameworks for halal medicines, the demand for verifiably halal pharmaceutical products is increasing significantly.
Gelatin is the most widely discussed non-halal ingredient in pharmaceuticals. It is used extensively in capsule shells (both hard and soft gel capsules) and as a stabiliser in some vaccines. The majority of pharmaceutical-grade gelatin is derived from porcine (pig) sources, making it haram.
Halal alternatives include bovine gelatin from halal-slaughtered cattle, fish gelatin, and plant-based alternatives such as hydroxypropyl methylcellulose (HPMC) capsules and carrageenan-based soft gels. HPMC capsules are now widely available and are used by several major pharmaceutical companies for halal-certified products.
Ethanol is used as a solvent in many liquid medicines, tinctures, and some injectable formulations. The permissibility of alcohol in medicines is a matter of scholarly debate in Islamic jurisprudence. Some scholars permit its use when it is present in small quantities as a manufacturing necessity (not for intoxication) and when no halal alternative exists. Others take a stricter position, considering any alcohol-containing medicine to be impermissible when alternatives are available.
Pharmaceutical companies developing halal products typically avoid alcohol-based solvents where technically feasible, using water-based or glycerin-based alternatives.
Beyond gelatin and alcohol, other pharmaceutical excipients may be animal-derived: magnesium stearate (potentially from animal tallow), lactose (from non-halal-certified dairy sources), and stearic acid. While these ingredients are less prominent in public discussion, they are scrutinised during halal pharmaceutical certification audits.
Malaysia is the most advanced country in halal pharmaceutical regulation. The Malaysian Standard MS 2424:2019 provides guidelines for halal pharmaceuticals, covering raw materials, manufacturing processes, packaging, storage, and distribution. JAKIM works with the National Pharmaceutical Regulatory Agency (NPRA) to oversee halal pharmaceutical certification.
Malaysia's approach treats halal pharmaceutical certification as complementary to, not a replacement for, standard pharmaceutical Good Manufacturing Practice (GMP) requirements. A halal-certified pharmaceutical product must first meet all GMP and safety standards before halal compliance is assessed.
Indonesia's halal product assurance law (Jaminan Produk Halal, or JPH) includes pharmaceuticals within its scope. The law mandates halal certification for pharmaceutical products, with implementation phased over several years. BPJPH (Badan Penyelenggara Jaminan Produk Halal) oversees the certification process, with technical assessment delegated to approved Halal Inspection Bodies.
GCC countries have been developing halal pharmaceutical guidelines through the Gulf Standards Organization (GSO). While halal pharmaceutical certification is not yet mandatory in most GCC countries, consumer demand and government interest in halal economy development are driving regulatory attention.
SMIIC has published OIC/SMIIC 8:2020, a guideline for halal pharmaceutical products. This standard is intended to provide a common framework for OIC member states, covering raw material requirements, manufacturing conditions, and testing. As with other SMIIC standards, adoption by individual countries varies.
Replacing non-halal ingredients in established pharmaceutical formulations is not trivial. Changing a capsule shell from porcine gelatin to HPMC, for example, may affect drug dissolution rates, stability, and bioavailability. Reformulated products may need to undergo new stability testing and, in some jurisdictions, additional regulatory approval. These costs can be significant, particularly for generic manufacturers operating on thin margins.
Pharmaceutical supply chains are global and highly complex. Active pharmaceutical ingredients (APIs) and excipients are often sourced from multiple countries. Tracing the halal status of every ingredient and ensuring cross-contamination prevention throughout the manufacturing process requires dedicated quality systems and supply chain management.
Islamic jurisprudence recognises a principle of necessity (darurah) that permits the use of otherwise prohibited substances when life or health is at risk and no halal alternative is available. This principle complicates the halal pharmaceutical market: if a haram medicine is permissible when no halal alternative exists, the commercial case for developing halal alternatives depends partly on how broadly or narrowly scholars and consumers interpret this principle.
Over-the-counter (OTC) medicines and dietary supplements represent the most accessible opportunity for halal pharmaceutical products. These products have lower regulatory barriers than prescription medicines, and consumers have direct purchasing choice. Halal-certified vitamins, pain relievers, cough medicines, and digestive aids can be marketed directly to halal-conscious consumers through retail and e-commerce channels.
Pharmaceutical contract manufacturers (CDMOs) that invest in halal-certified production lines can serve multiple brands and markets. As demand for halal pharmaceuticals grows, CDMOs with established halal credentials will be well positioned to capture manufacturing contracts from companies that lack their own halal-certified facilities.
Vaccine formulations that use porcine-derived gelatin as a stabiliser have been a source of concern for Muslim communities. Several vaccine manufacturers have developed gelatin-free or halal gelatin-based formulations, and this trend is expected to continue as governments in Muslim-majority countries prioritise halal compliance in national immunisation programs.
The halal pharmaceutical market is at an earlier stage of development than halal food or halal cosmetics. Regulatory frameworks are still being established in many countries, consumer awareness is growing but uneven, and the reformulation challenges are real.
However, the fundamentals driving growth are strong: a large and growing Muslim population, increasing health awareness, regulatory mandates in key markets like Indonesia and Malaysia, and growing consumer demand for products that align with their religious values across all categories — not just food.
Pharmaceutical companies that begin investing in halal compliance now — through reformulation, supply chain transparency, and certification — will have a first-mover advantage as this market matures over the coming decade.
Market Research
Africa is home to over 400 million Muslims and the continent's halal market is growing faster than any other region. This analysis covers key markets, certification landscapes, infrastructure challenges, and the investment opportunity.
Market Research
An overview of Malaysia's leading halal food manufacturers, from multinational giants to fast-growing SMEs. Covers JAKIM certification, export markets, and what makes Malaysian halal food globally competitive.
Market Research
March 14, 2026 · 11 min
Australia exports over $4 billion in halal meat annually, making it one of the world's largest halal protein suppliers. This article covers how Australia built its halal certification infrastructure and key export markets.